Doctors should discuss financial concerns of cancer patients, study finds

May 17, 2013

(Medical Xpress)—Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at Duke Cancer Institute report.

Yet many patients who do broach the subject of finances believe it helps decrease costs.

Those findings, from a survey of 300 insured patients treated at Duke and affiliated clinics in rural North Carolina, suggest that doctors can play a role in easing financial worries just by taking the problem into account.

"We wanted to know whether patients wanted costs to impact their treatment decision," said Yousuf Zafar, M.D., MHS, assistant professor at Duke and lead author of the study slated for presentation June 3 at the 2013 Annual Meeting of the in Chicago (ASCO Abstract #6506). "We know many patients are burdened by out-of-pocket costs, but we know little about how those costs impact decision making."

Zafar said 57 percent of the participants in the Duke survey said they wanted to talk about treatment costs with their doctors, but only 19 percent actually had that conversation.

Of patients with the highest degree of – determined by a gauge commonly used in the field – 61 percent said they wanted to discuss treatment costs with their doctors, but only 25 percent had done so.

"There's a real disconnect," Zafar said. "Even people with the highest needs aren't bringing up costs as part of the decision-making process."

Why? Some responded that they were embarrassed; others didn't think it was something the doctor could help with or should worry about.

But many – 28 percent - said they wanted the best possible care regardless of cost. Zafar said other studies have shown that patient's fear receiving less-optimal treatments if they raise concerns about costs.

"We found that when patients did talk about costs with their doctors, many felt they gained something from the discussion – that their expenses were reduced," Zafar said. "This suggests that the perceived barriers to the cost conversation aren't real, and we need to do more to foster a dialogue around these issues."

Zafar said doctors should have tools to identify the patients who need help, so they can direct patients to the appropriate resources.

"Patients rely on oncologists to help with making. A core tenet of shared decision-making is considering patients' values and preferences," Zafar said. "Without considering costs to the patient as part of the treatment process, we have to ask: are we really taking all patient preferences into account?

"With today's evolving health insurance landscape, cancer treatment-related costs to patients are more important than ever," Zafar said. "These data are particularly interesting, and liberating, as they indicate a two-way interest in cost discussions. As providers, our team is convinced that cost discussions with our patients is important, and knowing that patients want to have these discussions should give us confidence in making this a routine practice."

Explore further: Medical bills force cancer patients to skimp on care and necessities

Related Stories

Medical bills force cancer patients to skimp on care and necessities

June 7, 2011
(Medical Xpress) -- Even when covered by health insurance, cancer patients face mounting out-of-pocket expenses that force some to avoid filling prescriptions, skip doctor appointments, and scale back on food and other necessities.

Study finds broad support for rationing of some types of cancer care

May 15, 2013
The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don't improve survival or quality of life, according to results of a new study ...

Patient preference doesn't affect chemo in advanced CRC

September 21, 2012
(HealthDay)—For patients with metastatic colorectal cancer (mCRC), most patients are treated with chemotherapy, even if they express negative or marginal preferences, according to a study published online Sept. 12 in Cancer.

Study finds virtual colonoscopy is used appropriately, may expand screening to more patients

April 5, 2013
In 2009, the Centers for Medicare and Medicaid Services (CMS) halted reimbursement for so-called "virtual colonoscopy" for routine colon-cancer screening in asymptomatic patients, in part due to concerns over how this procedure, ...

Patient preferences often ignored in treatment decisions, warn experts

November 8, 2012
Patients' preferences are often misinterpreted or ignored in treatment decisions, leading to a "silent misdiagnosis" that is damaging to both doctors and patients, warn experts on BMJ today.

'Do no harm': Patient-centered end-of-life care means happier patients who live longer

March 21, 2013
(Medical Xpress)—New doctors take an oath to do no harm, but many physicians, in their zeal to prolong people's lives, often end up exposing patients to aggressive treatments that don't improve outcomes and that drive up ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.